Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Mar Vales-Gomez"'
Autor:
Margit Anthofer, Markus Windisch, Rosa Haller, Sandra Ehmann, Sebastian Wrighton, Michael Miller, Lorenz Schernthanner, Iris Kufferath, Silvia Schauer, Barbara Jelušić, Sabine Kienesberger, Ellen L. Zechner, Gernot Posselt, Mar Vales-Gomez, Hugh T. Reyburn, Gregor Gorkiewicz
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundHelicobacter pylori (H. pylori) uses various strategies that attenuate mucosal immunity to ensure its persistence in the stomach. We recently found evidence that H. pylori might modulate the natural killer group 2, member 2 (NKG2D) system.
Externí odkaz:
https://doaj.org/article/7eb6600bc12f45f996cdae771223c74f
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/33e8f85ccdb54fb6839a033f11e28822
Autor:
Sara G Dosil, Sheila Lopez-Cobo, Ana Rodriguez-Galan, Irene Fernandez-Delgado, Marta Ramirez-Huesca, Paula Milan-Rois, Milagros Castellanos, Alvaro Somoza, Manuel José Gómez, Hugh T Reyburn, Mar Vales-Gomez, Francisco Sánchez Madrid, Lola Fernandez-Messina
Publikováno v:
eLife, Vol 11 (2022)
Natural killer (NK) cells recognize and kill target cells undergoing different types of stress. NK cells are also capable of modulating immune responses. In particular, they regulate T cell functions. Small RNA next-generation sequencing of resting a
Externí odkaz:
https://doaj.org/article/010fa4a4b14e4b4dbab5d7d3350e67db
Autor:
Carmen Campos-Silva, Silvia López-Borrego, María José Felgueres, Gloria Esteso, Mar Vales-Gomez
Publikováno v:
Critical Reviews in Immunology. 42:21-40
The identification of biomarkers allowing diagnostics, prognostics and patient classification is still a challenge in oncological research for patient management. Improvements in patient survival achieved with immunotherapies substantiate that biomar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a7544924b5c7a884292aef554a5089
https://doi.org/10.1615/critrevimmunol.2022045263
https://doi.org/10.1615/critrevimmunol.2022045263
Autor:
NACHO AGUILO, Eduardo Moreo, Iñaqui Robles, Claudia Guerrero, Aitor Jarit, María José Felgueres, Gloria Esteso, Iratxe Uranga-Murillo, Santiago Uranga, Ana Belen Gomez, Julian Pardo, Carlos Martin, Mar Vales-Gomez, Carlos del Fresno, David Sancho
Intravesical administration of BCG was the first immunotherapy approved by the FDA and it is still nowadays the treatment of choice for a subset of non-muscle invasive bladder cancer patients. Considering this precedent and the strong capabilities of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac5c6f628eae5b6ab8e8341a7e19228b
https://doi.org/10.21203/rs.3.rs-2086495/v1
https://doi.org/10.21203/rs.3.rs-2086495/v1
Autor:
Sara G Dosil, Sheila Lopez-Cobo, Ana Rodriguez-Galan, Irene Fernandez-Delgado, Marta Ramirez-Huesca, Paula Milan-Rois, Milagros Castellanos, Alvaro Somoza, Manuel José Gómez, Hugh T Reyburn, Mar Vales-Gomez, Francisco Sánchez Madrid, Lola Fernandez-Messina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::715d2c0690559bcf993eaeb615081eab
https://doi.org/10.7554/elife.76319.sa2
https://doi.org/10.7554/elife.76319.sa2
Autor:
María-José Felgueres, Gloria Esteso, Álvaro F. García-Jiménez, Ana Dopazo, Nacho Aguiló, Carmen Mestre-Durán, Luis Martínez-Piñeiro, Antonio Pérez-Martínez, Hugh T. Reyburn, Mar Valés-Gómez
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract The short-lived nature and heterogeneity of Natural Killer (NK) cells limit the development of NK cell-based therapies, despite their proven safety and efficacy against cancer. Here, we describe the biological basis, detailed phenotype and f
Externí odkaz:
https://doaj.org/article/bd24417e2d61481aba2a499fb276ab1b
Autor:
Eduardo Moreo, Aitor Jarit-Cabanillas, Iñaki Robles-Vera, Santiago Uranga, Claudia Guerrero, Ana Belén Gómez, Pablo Mata-Martínez, Luna Minute, Miguel Araujo-Voces, María José Felgueres, Gloria Esteso, Iratxe Uranga-Murillo, Maykel Arias, Julián Pardo, Carlos Martín, Mar Valés-Gómez, Carlos del Fresno, David Sancho, Nacho Aguiló
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer. Previous studies have demonstrated that intravenous (IV) administration of
Externí odkaz:
https://doaj.org/article/cddf6509eb5149ae82e3ae71ebde6322
Autor:
Daniel Fernández-Soto, Álvaro F. García-Jiménez, José M. Casasnovas, Mar Valés-Gómez, Hugh T. Reyburn
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionIt is now clear that coronavirus disease 19 (COVID-19) severity is associated with a dysregulated immune response, but the relative contributions of different immune cells is still not fully understood. SARS CoV-2 infection triggers marke
Externí odkaz:
https://doaj.org/article/393746ad871c479da14e43b119e05dbb
Autor:
Gloria Esteso, María José Felgueres, Álvaro F. García-Jiménez, Christina Reyburn-Valés, Alberto Benguría, Enrique Vázquez, Hugh T. Reyburn, Nacho Aguiló, Carlos Martín, Eugenia Puentes, Ingrid Murillo, Esteban Rodríguez, Mar Valés-Gómez
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTBacillus Calmette-Guérin (BCG), the nonpathogenic Mycobacterium bovis strain used as tuberculosis vaccine, has been successfully used as treatment for non-muscle invasive bladder cancer for decades, and suggested to potentiate cellular and h
Externí odkaz:
https://doaj.org/article/d8013a98d0e348c39add8c2094c07125